BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee SM, Kim HS, Lee S, Lee JW. Emerging role of 18F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinoma. World J Gastroenterol 2019; 25(11): 1289-1306 [PMID: 30918424 DOI: 10.3748/wjg.v25.i11.1289]
URL: https://www.wjgnet.com/1007-9327/full/v25/i11/1289.htm
Number Citing Articles
1
Ximin Shi, Haiqun Xing, Xiaobo Yang, Fang Li, Shaobo Yao, Jia Congwei, Haitao Zhao, Marcus Hacker, Li Huo, Xiang Li. Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot studyEuropean Journal of Nuclear Medicine and Molecular Imaging 2021; 48(5): 1593 doi: 10.1007/s00259-020-05070-9
2
Ji Hye Min, Seong Hyun Kim, Jeong Ah Hwang, Seung Hyup Hyun, Sang Yun Ha, Seo-Youn Choi, Seon Woo Kim, Hye Seung Kim. Prognostic value of LI-RADS category on gadoxetic acid–enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomasEuropean Radiology 2021; 31(6): 3649 doi: 10.1007/s00330-020-07378-4
3
Emile B. Veenstra, Simeon J. S. Ruiter, Robbert J. de Haas, Koert P. de Jong, Paola A. Erba, Rudi A. J. O. Dierckx, Walter Noordzij. A dual-tracer approach using [11C]CH and [18F]FDG in HCC clinical decision makingEJNMMI Research 2023; 13(1) doi: 10.1186/s13550-023-01024-y
4
Naresh Damuka, Meghana Dodda, Kiran Kumar Solingapuram Sai. Cancer BiomarkersMethods in Molecular Biology 2022; 2413: 23 doi: 10.1007/978-1-0716-1896-7_4
5
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III RecommendationsJournal of Clinical and Experimental Hepatology 2024; 14(1): 101269 doi: 10.1016/j.jceh.2023.08.005
6
Wenjie Miao, Pei Nie, Guangjie Yang, Yangyang Wang, Lei Yan, Yujun Zhao, Ting Yu, Mingming Yu, Fengyu Wu, Wei Rao, Zhenguang Wang. An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantationEuropean Journal of Nuclear Medicine and Molecular Imaging 2021; 48(11): 3656 doi: 10.1007/s00259-021-05328-w
7
Indah Jamtani, Kwang-Woong Lee, Yunhee Choi, YoungRok Choi, Jeong-Moo Lee, Eui-Soo Han, Kwangpyo Hong, Gyu-Seong Choi, Jong Man Kim, Nam-Joon Yi, Suk Kyun Hong, Jeik Byun, Su Young Hong, Sanggyeun Suh, Jae-Won Joh, Kyung-Suk Suh. Tailored Prediction Model of Survival after Liver Transplantation for Hepatocellular CarcinomaJournal of Clinical Medicine 2021; 10(13): 2869 doi: 10.3390/jcm10132869
8
Barbara Katharina Geist, Jingnan Wang, Xuezhu Wang, Jianzhen Lin, Xu Yang, Hui Zhang, Fang Li, Haitao Zhao, Marcus Hacker, Li Huo, Xiang Li. Comparison of different kinetic models for dynamic 18F-FDG PET/CT imaging of hepatocellular carcinoma with various, also dual-blood input functionPhysics in Medicine & Biology 2020; 65(4): 045001 doi: 10.1088/1361-6560/ab66e3
9
Eric Vibert, Myron Schwartz, Kim M. Olthoff. Advances in resection and transplantation for hepatocellular carcinomaJournal of Hepatology 2020; 72(2): 262 doi: 10.1016/j.jhep.2019.11.017
10
Yoshiyuki Ida, Hideyuki Tamai, Naoki Shingaki, Ryo Shimizu, Shuya Maeshima, Takao Maekita, Mikitaka Iguchi, Masaki Terada, Masayuki Kitano. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with small hepatocellular carcinoma treated by radiofrequency ablationCancer Imaging 2020; 20(1) doi: 10.1186/s40644-020-00356-5
11
Ana‐Maria Bucalau, Benoît Collette, Illario Tancredi, Irina Vierasu, Fadi Tannouri, Martina Pezzullo, Rodrigo Moreno‐Reyes, Gontran Verset. 166Ho‐RadioEmbolizaTiOn Using personalized prediCtive dosimetry in patients with Hepatocellular carcinoma: A prospective, single‐centre study (RETOUCH)Liver International 2024;  doi: 10.1111/liv.15923
12
Ana Margarida Abrantes, Ana Salomé Pires, Lúcia Monteiro, Ricardo Teixo, Ana Rita Neves, Nuno Tiago Tavares, Inês Alexandra Marques, Maria Filomena Botelho. Tumour functional imaging by PETBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(6): 165717 doi: 10.1016/j.bbadis.2020.165717
13
Masao Nakajima, Yukio Tokumitsu, Yoshitaro Shindo, Hiroto Matsui, Satoshi Matsukuma, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Tatsuya Ioka, Hiroaki Nagano. The Recent Development of the Surgical Treatment for Hepatocellular CarcinomaApplied Sciences 2021; 11(5): 2023 doi: 10.3390/app11052023
14
Shengpan Jiang, Xiaoqing Gao, Yueli Tian, Jie Chen, Yichun Wang, Yaqun Jiang, Yong He. The potential of 18F-FDG PET/CT metabolic parameter-based nomogram in predicting the microvascular invasion of hepatocellular carcinoma before liver transplantationAbdominal Radiology 2024; 49(5): 1444 doi: 10.1007/s00261-023-04166-8
15
Pietro Zucchetta, Carmelo Lacognata, Francesca Girardi, Alessandro Spimpolo, Filippo Crimì, Giulio Cabrelle, Chiara Zanon, Patrizia Boccagni, Laura Evangelista, Diego Cecchin, Umberto Cillo. [18F]FDG PET/MRI in the follow-up of hepatocellular carcinoma after liver transplantationNuclear Medicine Communications 2022; 43(3): 359 doi: 10.1097/MNM.0000000000001518
16
Ren-Cai Lu, Bo She, Wen-Tao Gao, Yun-Hai Ji, Dong-Dong Xu, Quan-Shi Wang, Shao-Bo Wang. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospectsWorld Journal of Gastroenterology 2019; 25(32): 4682-4695 doi: 10.3748/wjg.v25.i32.4682
17
Recep Erçin SÖNMEZ, Florent L. BESSON, Jerome GHİDAGLIA, Maïté LEWIN, Lea GOMEZ, Chady SALLOUM, Gabriella PITTAU, Oriana CIACIO, Marc Antoine ALLARD, Daniel CHERQUI, René ADAM, Antonio SA CUNHA, Daniel AZOULAY, Eric VİBERT, Nicolas GOLSE. Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center studyThe Quarterly Journal of Nuclear Medicine and Molecular Imaging 2023; 67(3) doi: 10.23736/S1824-4785.22.03485-9
18
Jingnan Wang, Yunwen Shao, Bowei Liu, Xuezhu Wang, Barbara Katharina Geist, Xiang Li, Fang Li, Haitao Zhao, Marcus Hacker, Haiyan Ding, Hui Zhang, Li Huo. Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input functionBMC Medical Imaging 2021; 21(1) doi: 10.1186/s12880-021-00623-2
19
Yan Hu, Guobing Liu, Haojun Yu, Jianying Gu, Hongcheng Shi. Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging 2022; 49(10): 3538 doi: 10.1007/s00259-022-05772-2
20
Bing-Quan Lin, Wen-Biao Zhang, Jing Zhao, Xu-Hui Zhou, Yong-Jiang Li, Jun Deng, Qin Zhao, Gui Fu, Chuan-Miao Xie, Yi-Kai Xu, Guo-Kai Feng. An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in MiceJournal of Hepatocellular Carcinoma 2021; : 645 doi: 10.2147/JHC.S312921
21
Yanjie Wang, Yuan Sun, Xueyuan Zeng, Rongqiang Zhuang, Jinxiong Huang, Xianzhong Zhang, Zhide Guo, Yesen Li. 68Ga-Labeled TMTP1 Modified with d-Amino Acid for Positron Emission Tomography Diagnosis of Highly Metastatic Hepatocellular CarcinomaJournal of Medicinal Chemistry 2024; 67(3): 2165 doi: 10.1021/acs.jmedchem.3c02090
22
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal MalignanciesRadiologic Clinics of North America 2021; 59(5): 737 doi: 10.1016/j.rcl.2021.06.001
23
Beatriz Sanchez de Blas, Alvaro G. Temprano, Jose J. G. Marin, Marta R. Romero. Monitoring the hepatobiliary function using image techniques and labeled cholephilic compoundsExploration of Digestive Diseases 2023; : 18 doi: 10.37349/edd.2023.00015
24
Filiz Çelebi, Kourosh Yaghouti, Emetullah Cindil, Gülen Bülbül Dogusoy, Yaman Tokat, Cem Balcı. The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic NeoplasmsAcademic Radiology 2021; 28(2): 189 doi: 10.1016/j.acra.2020.01.026
25
Donghe Chen, Chengdong Chang, Yafei Zhang, Shuye Yang, Guolin Wang, Lili Lin, Xin Zhao, Kui Zhao, Xinhui Su. Different Features of 18F-FAPI, 18F-FDG PET/CT and MRI in the Evaluation of Extrahepatic Metastases and Local Recurrent Hepatocellular Carcinoma (HCC): A Case Report and Review of the LiteratureCancer Management and Research 2022; : 2649 doi: 10.2147/CMAR.S374916
26
Xuezhu Wang, Xu Yang, Jingnan Wang, Chengyan Dong, Jie Ding, Meiqi Wu, Yanyu Wang, Haiyan Ding, Hui Zhang, Xinting Sang, Haitao Zhao, Li Huo. Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted AgentsJournal of Hepatocellular Carcinoma 2023; : 587 doi: 10.2147/JHC.S401647
27
P.O. Korol, M.S. Lukashenko, O.V. Shcherbina, V.P. Ivchuk, Yu.P. Severyn. The role of positron emission tomography in the diagnosis and treatment of oncological diseases of the hepatobiliary systemRadiation Diagnostics, Radiation Therapy 2022; 13(4) doi: 10.37336/2707-0700-2022-4-5
28
Edouard Reizine, Julia Chalaye, Sebastien Mule, Helene Regnault, Clara Perrin, Julien Calderaro, Alexis Laurent, Giuliana Amaddeo, Hicham Kobeiter, Vania Tacher, Emmanuel Itti, Alain Luciani. Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular CarcinomaAmerican Journal of Roentgenology 2022; 218(2): 359 doi: 10.2214/AJR.21.26485
29
Senri Kondo, Shoji Oura. Pitfalls on image evaluation of tumor viability and anti-tumor efficacy in metastatic mucinous breast cancer: A case reportRadiology Case Reports 2024; 19(12): 6093 doi: 10.1016/j.radcr.2024.09.067
30
Wenzhi Jia, Qianyun Wu, Xiaofeng Yu, Mengqin Shen, Ruixue Zhang, Jiajin Li, Li Zhao, Gang Huang, Jianjun Liu. Prognostic values of ALDOB expression and 18F-FDG PET/CT in hepatocellular carcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1044902
31
Nandakumar Menon, Mark Mandelkern. Utility of PET Scans in the Diagnosis and Management of Gastrointestinal TumorsDigestive Diseases and Sciences 2022; 67(10): 4633 doi: 10.1007/s10620-022-07616-3
32
Miikka-Juhani Honka, Eleni Rebelos, Simona Malaspina, Pirjo Nuutila. Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and CancerMetabolites 2022; 12(4): 321 doi: 10.3390/metabo12040321
33
Karthikeyan Subramanian, Piyush Aggarwal, Lance T. Hall, Harmandeep Singh, Amol M. Takalkar, Bhagwant Rai Mittal. Molecular Imaging and Therapy2023; : 121 doi: 10.36255/molecular-imaging-of-hepatobiliary-cancers
34
Aida Sabaté-Llobera, Judit Mestres-Martí, Gabriel Reynés-Llompart, Laura Lladó, Kristel Mils, Teresa Serrano, Montserrat Cortés-Romera, Esther Bertran, Isabel Fabregat, Emilio Ramos. 2-[18F]FDG PET/CT as a Predictor of Microvascular Invasion and High Histological Grade in Patients with Hepatocellular CarcinomaCancers 2021; 13(11): 2554 doi: 10.3390/cancers13112554
35
Han Jiang, Mei Tian. Transpathology2024; : 297 doi: 10.1016/B978-0-323-95223-1.00009-6
36
Cyriac A Philips, Sasidharan Rajesh, Dinu C Nair, Rizwan Ahamed, Jinsha K Abduljaleel, Philip Augustine. Hepatocellular Carcinoma in 2021: An Exhaustive UpdateCureus 2021;  doi: 10.7759/cureus.19274
37
Raluca Mititelu, Alexandru Mitoi, Catalin Mazilu, Mariana Jinga, Florentina Ionita Radu, Ana Bucurica, Teodora Mititelu, Sandica Bucurica. Advancements in hepatocellular carcinoma management: the role of 18F-FDG PET-CT in diagnosing portal vein tumor thrombosisNuclear Medicine Communications 2024; 45(8): 651 doi: 10.1097/MNM.0000000000001863
38
Anne-Leen Deleu, Machaba Junior Sathekge, Alex Maes, Bart De Spiegeleer, Mike Sathekge, Christophe Van de Wiele. Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A ReviewBiomedicines 2020; 8(9): 304 doi: 10.3390/biomedicines8090304